Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice

被引:184
|
作者
Kumari, Pratima [1 ]
Rothan, Hussin A. [1 ]
Natekar, Janhavi P. [1 ]
Stone, Shannon [1 ]
Pathak, Heather [1 ]
Strate, Philip G. [1 ]
Arora, Komal [1 ]
Brinton, Margo A. [1 ]
Kumar, Mukesh [1 ]
机构
[1] Georgia State Univ, Dept Biol, Coll Arts & Sci, Atlanta, GA 30303 USA
来源
VIRUSES-BASEL | 2021年 / 13卷 / 01期
基金
美国国家卫生研究院;
关键词
SARS-CoV-2; COVID-19; K18-hACE2; mice; neuroinvasion; neuroinflammation; encephalitis; MOUSE HEPATITIS-VIRUS; VIRAL DISEASES; OLFACTORY-BULB; INFECTION; CORONAVIRUS; BRAIN; MODEL; PATHOGENESIS; DYSFUNCTION; DEFENSE;
D O I
10.3390/v13010132
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection can cause neurological disease in humans, but little is known about the pathogenesis of SARS-CoV-2 infection in the central nervous system (CNS). Herein, using K18-hACE2 mice, we demonstrate that SARS-CoV-2 neuroinvasion and encephalitis is associated with mortality in these mice. Intranasal infection of K18-hACE2 mice with 10(5) plaque-forming units of SARS-CoV-2 resulted in 100% mortality by day 6 after infection. The highest virus titers in the lungs were observed on day 3 and declined on days 5 and 6 after infection. By contrast, very high levels of infectious virus were uniformly detected in the brains of all the animals on days 5 and 6. Onset of severe disease in infected mice correlated with peak viral levels in the brain. SARS-CoV-2-infected mice exhibited encephalitis hallmarks characterized by production of cytokines and chemokines, leukocyte infiltration, hemorrhage and neuronal cell death. SARS-CoV-2 was also found to productively infect cells within the nasal turbinate, eye and olfactory bulb, suggesting SARS-CoV-2 entry into the brain by this route after intranasal infection. Our data indicate that direct infection of CNS cells together with the induced inflammatory response in the brain resulted in the severe disease observed in SARS-CoV-2-infected K18-hACE2 mice.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] In Vitro and In Vivo Therapeutic Potential of 6,6'-Dihydroxythiobinupharidine (DTBN) from Nuphar lutea on Cells and K18-hACE2 Mice Infected with SARS-CoV-2
    Weiss, Shay
    Waidha, Kamran
    Rajendran, Saravanakumar
    Benharroch, Daniel
    Khalilia, Jannat
    Levy, Haim
    Bar-David, Elad
    Golan-Goldhirsh, Avi
    Gopas, Jacob
    Ben-Shmuel, Amir
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (09)
  • [42] SARS-CoV-2: is there neuroinvasion?
    Conor McQuaid
    Molly Brady
    Rashid Deane
    Fluids and Barriers of the CNS, 18
  • [43] Functional heterogeneity of mesenchymal stem cells and their therapeutic potential in the K18-hACE2 mouse model of SARS-CoV-2 infection
    da Silva, Katia Nunes
    Marim, Fernanda Martins
    Rocha, Gisele Vieira
    Costa-Ferro, Zaquer Suzana Munhoz
    Franca, Luciana Souza de Aragao
    Nonaka, Carolina Kymie Vasques
    Paredes, Bruno Diaz
    Rossi, Erik Aranha
    Loiola, Erick Correia
    Adanho, Corynne Stephanie Ahouefa
    Cunha, Rachel Santana
    da Silva, Mayck Medeiros Amaral
    Cruz, Fernanda Ferreira
    Costa, Vivian Vasconcelos
    Zanette, Dalila Luciola
    Rocha, Clarissa Araujo Gurgel
    Aguiar, Renato Santana
    Rocco, Patricia Rieken Macedo
    Souza, Bruno Solano de Freitas
    STEM CELL RESEARCH & THERAPY, 2025, 16 (01)
  • [44] SARS-CoV-2: is there neuroinvasion?
    McQuaid, Conor
    Brady, Molly
    Deane, Rashid
    FLUIDS AND BARRIERS OF THE CNS, 2021, 18 (01)
  • [45] Comparison of the Pathogenicity of SARS-CoV-2 Delta and Omicron Variants by Analyzing the Expression Patterns of Immune Response Genes in K18-hACE2 Transgenic Mice
    Kuruppuarachchi, Kuruppu Arachchillage Praboda Priyangi
    Jang, Yunyueng
    Seo, Sang Heui
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2022, 27 (11):
  • [46] DNA immunization with in silico predicted T-cell epitopes protects against lethal SARS-CoV-2 infection in K18-hACE2 mice
    Persson, Gry
    Restori, Katherine H.
    Emdrup, Julie Hincheli
    Schussek, Sophie
    Klausen, Michael Schantz
    Nicol, McKayla J.
    Katkere, Bhuvana
    Rono, Birgitte
    Kirimanjeswara, Girish
    Sorensen, Anders Bundgaard
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [47] Improved survival of SARS COV-2-infected K18-hACE2 mice treated with adenosine A2AR agonist
    Mann, Barbara J.
    Chhabra, Preeti
    Ma, Mingyang
    Brovero, Savannah G.
    Hannan, Riley T.
    Sturek, Jeffrey M.
    Jones, Marieke K.
    Linden, Joel
    Brayman, Kenneth L.
    HELIYON, 2023, 9 (08)
  • [48] Intravenous, Intratracheal, and Intranasal Inoculation of Swine with SARS-CoV-2
    Buckley, Alexandra
    Falkenberg, Shollie
    Martins, Mathias
    Laverack, Melissa
    Palmer, Mitchell V.
    Lager, Kelly
    Diel, Diego G.
    VIRUSES-BASEL, 2021, 13 (08):
  • [49] Differential responses of lung and intestinal microbiota to SARS-CoV-2 infection: a comparative study of the Wuhan and Omicron strains in K18-hACE2 Tg mice
    Chae Won Kim
    Keun Bon Ku
    Insu Hwang
    Hi Eun Jung
    Kyun-Do Kim
    Heung Kyu Lee
    Laboratory Animal Research, 41 (1)
  • [50] The Protective Efficacy of a SARS-CoV-2 Vaccine Candidate B.1.351V against Several Variant Challenges in K18-hACE2 Mice
    Yang, Jie
    Fan, Huifen
    Yang, Anna
    Wang, Wenhui
    Wan, Xin
    Lin, Fengjie
    Yang, Dongsheng
    Wu, Jie
    Wang, Kaiwen
    Li, Wei
    Cai, Qian
    You, Lei
    Pang, Deqin
    Lu, Jia
    Guo, Changfu
    Shi, Jinrong
    Sun, Yan
    Li, Xinguo
    Duan, Kai
    Shen, Shuo
    Meng, Shengli
    Guo, Jing
    Wang, Zejun
    VACCINES, 2024, 12 (07)